Related Experiment Video
Updated: Jun 11, 2025

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Comparison of Risk Factors Between Lean and Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease in
Weixia Sun1, Yingqi Lv1, Li Wang2
1Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China; Key Laboratory of Environmental Medicine Engineering of Ministry of Education, Southeast University, Nanjing, China.
In type 2 diabetes mellitus (T2DM), lean individuals show distinct liver steatosis and fibrosis risk factors compared to nonlean individuals. Management strategies should be tailored based on these differences.
Area of Science:
- Endocrinology
- Hepatology
- Metabolic Diseases
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a growing concern in type 2 diabetes mellitus (T2DM).
- Understanding risk factors for liver steatosis and fibrosis in T2DM patients, particularly differentiating between lean and nonlean individuals, is crucial for effective management.
- Previous studies have primarily focused on overweight or obese populations, potentially overlooking unique aspects in lean T2DM patients.
Purpose of the Study:
- To investigate and compare the prevalence and risk factors of liver steatosis and fibrosis between lean (BMI < 23 kg/m² ) and nonlean (BMI ≥ 23 kg/m² ) patients with type 2 diabetes mellitus.
- To identify specific clinical and metabolic differences associated with liver disease in these two groups.
Main Methods:
- A multicenter study involving 1762 patients with T2DM.
- Transient elastography was used to diagnose liver steatosis and fibrosis.
- Collection of clinical data including diabetes status, serum lipids, inflammatory markers, and body mass index (BMI).
- Analysis of risk factors for liver steatosis and fibrosis in lean versus nonlean groups.
Main Results:
- Prevalence of liver steatosis and fibrosis in the lean group was 44.7% and 23.4%, respectively.
- Lean patients exhibited higher rates of hypertension and cardiovascular disease.
- In lean patients with liver steatosis/fibrosis, older age, longer diabetes duration, lower insulin resistance (HOMA-IR), and lower serum lipids were observed.
- BMI, visceral fat area, and triglycerides correlated with liver steatosis in both groups, but lipid profiles differed.
- Insulin resistance, BMI, and lipid levels were not significantly associated with fibrosis in the lean group.
Conclusions:
- Liver steatosis and fibrosis in lean T2DM patients are less associated with insulin resistance compared to nonlean patients.
- Distinct risk factors for liver steatosis necessitate risk stratification and individualized management approaches for lean and nonlean T2DM individuals.
- Further research into the specific mechanisms driving liver disease in lean T2DM populations is warranted.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Obesity

